Apogee shares positive mid-stage maintenance data for eczema drug that could challenge Dupixent, Ebglyssnews2026-03-23T11:08:26+00:00March 23rd, 2026|Endpoints News|
Arikayce could become Insmed’s second blockbuster following late-stage win in lung infectionnews2026-03-23T11:01:00+00:00March 23rd, 2026|Endpoints News|
Sanofi extends $180M to California T cell engager startup Kalinews2026-03-23T11:00:42+00:00March 23rd, 2026|Endpoints News|
Pfizer’s Lyme disease vaccine trial hampered by lack of casesnews2026-03-23T10:45:45+00:00March 23rd, 2026|Endpoints News|
Frustrated Lewis pairs mark 20 years of metal-free catalysisnews2026-03-23T09:43:00+00:00March 23rd, 2026|Chemistry World|
